Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers in the territories of Europe, Australia and New Zealand. Philogen will complete pivotal clinical trials for the product in Europe
Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
The latest extension of Masimo and Philips’ ongoing collaboration will help enable clinicians to make quick and informed decisions without the need for additional monitoring equipment
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Subscribe To Our Newsletter & Stay Updated
